DUBLIN, November 13, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/lkxw7x/blood_glucose) has announced the addition of the "Blood Glucose Monitoring Devices - Global Strategic Business Report" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.
This report analyzes the worldwide markets for Blood Glucose Monitoring Devices in US$ Million by the following Product Segments:
- Blood Glucose Strips
- Blood Glucose Meters
- Lancets.
The report profiles 94 companies including many key and niche players such as:
- Abbott Diabetes Care Inc.
- Arkray Inc.
- Arkray USA Inc.
- Bayer Healthcare
- Bionime Corp.
- B. Braun Melsungen AG
- DexCom Inc.
- LifeScan Inc. Medtronic
- Nipro Diagnostics Inc.
- Nova Biomedical Corporation
- Roche Diagnostics Corp.
- Terumo Europe NV.
Key Topics Covered:
I. Introduction, Methodology & Product Definitions
II. Executive Summary
1. Industry Overview
2. Market Trends, Issues And Drivers
3. Diabetes - A Macro Perspective
4. Product Overview
5. Product Innovations/Introductions
6. Recent Industry Activity
7. Focus On Select Global Players
8. Global Market Perspective
III. Market
1. The United States
2. Canada
3. Japan
4. Europe
5. Asia-Pacific
6. Latin America
7. Rest Of World
IV. Competitive Landscape
Total Companies Profiled: 94 (including Divisions/Subsidiaries - 112 )
For more information visit http://www.researchandmarkets.com/research/lkxw7x/blood_glucose
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Glucose Testing
Share this article